Rong Hu

1.2k total citations
36 papers, 941 citations indexed

About

Rong Hu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Rong Hu has authored 36 papers receiving a total of 941 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 11 papers in Cancer Research and 7 papers in Oncology. Recurrent topics in Rong Hu's work include Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers) and RNA Research and Splicing (5 papers). Rong Hu is often cited by papers focused on Cancer-related molecular mechanisms research (6 papers), RNA modifications and cancer (6 papers) and RNA Research and Splicing (5 papers). Rong Hu collaborates with scholars based in China, United Kingdom and Australia. Rong Hu's co-authors include Lu Lu, Haiyan You, Lingyu Liu, Lianbo Wei, Xiaohui Wu, Mingqing Wang, Mingqing Wang, Ming Wang, Yanjing Wang and Wei Xiao and has published in prestigious journals such as Annals of Oncology, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

Rong Hu

36 papers receiving 934 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rong Hu China	16	551	193	124	113	106	36	941
Yuqi Fan China	23	599 1.1×	194 1.0×	177 1.4×	79 0.7×	71 0.7×	65	1.3k
Hossein Babaahmadi‐Rezaei Iran	17	425 0.8×	108 0.6×	127 1.0×	114 1.0×	59 0.6×	57	919
Jingzhou Chen China	22	709 1.3×	299 1.5×	158 1.3×	162 1.4×	128 1.2×	84	1.5k
Chang Pan China	18	450 0.8×	161 0.8×	76 0.6×	71 0.6×	107 1.0×	45	869
Baolin Liu China	14	422 0.8×	152 0.8×	79 0.6×	67 0.6×	86 0.8×	27	777
Wen Chen China	20	426 0.8×	163 0.8×	84 0.7×	70 0.6×	186 1.8×	62	1.1k
Xiaolei Sun China	23	882 1.6×	174 0.9×	154 1.2×	139 1.2×	107 1.0×	45	1.4k
Lei Feng China	18	363 0.7×	166 0.9×	81 0.7×	71 0.6×	127 1.2×	72	867
Xin Peng China	21	629 1.1×	261 1.4×	136 1.1×	68 0.6×	85 0.8×	50	1.1k

Countries citing papers authored by Rong Hu

Since Specialization

Citations

This map shows the geographic impact of Rong Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Hu more than expected).

Fields of papers citing papers by Rong Hu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Hu. The network helps show where Rong Hu may publish in the future.

Co-authorship network of co-authors of Rong Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Hu. A scholar is included among the top collaborators of Rong Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Hu. Rong Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Wanqun, Jibin Li, Qinan Yin, et al.. (2024). 801MO Efficacy and safety of a phase II study: Timdarpacept (IMM01) combined with azacitidine (AZA) as the first-line treatment in adults with chronic myelomonocytic leukemia (CMML). Annals of Oncology. 35. S597–S597. 1 indexed citations

Diao, Jianxin, Jiaxing Zhang, Hongsheng Zhou, et al.. (2024). Shenshuai Yingyang Jiaonang ameliorates chronic kidney disease-associated muscle atrophy in rats by inhibiting ferroptosis mediated by the HIF-1α/SLC7A11 pathway. Heliyon. 10(8). e29093–e29093. 6 indexed citations

Guan, Tianwang, Rong Hu, Zhongjie Huang, et al.. (2024). Targeting KAT7 inhibits the progression of colorectal cancer. Theranostics. 15(4). 1478–1495. 2 indexed citations

Li, Fang, Rong Hu, Chi Tang, et al.. (2024). CsGAT1 modulates GABA metabolism and positively regulates cold resistance in tea plants. International Journal of Biological Macromolecules. 282(Pt 3). 136985–136985. 3 indexed citations

Zhang, Honghao, Hao Wang, Yuxing Hu, et al.. (2024). Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma. Cancer Letters. 588. 216802–216802. 11 indexed citations

Hu, Rong, et al.. (2023). Runx2 regulates peripheral nerve regeneration to promote Schwann cell migration and re-myelination. Neural Regeneration Research. 19(7). 1575–1583. 12 indexed citations

Wu, Jing, Jiawen Huang, Rong Hu, et al.. (2022). Paeoniflorin Ameliorates Skeletal Muscle Atrophy in Chronic Kidney Disease via AMPK/SIRT1/PGC-1α-Mediated Oxidative Stress and Mitochondrial Dysfunction. Frontiers in Pharmacology. 13. 859723–859723. 24 indexed citations

Pei, Tingting, Daoqi Zhu, Sixia Yang, et al.. (2022). Bacteroides plebeius improves muscle wasting in chronic kidney disease by modulating the gut‐renal muscle axis. Journal of Cellular and Molecular Medicine. 26(24). 6066–6078. 23 indexed citations

Wang, Hao, et al.. (2022). Systematic pan-cancer landscape identifies CARM1 as a potential prognostic and immunological biomarker. BMC Genomic Data. 23(1). 7–7. 7 indexed citations

10.

Sun, Zengxian, et al.. (2022). Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2. International Journal of Molecular Medicine. 49(4). 11 indexed citations

11.

Pei, Tingting, Mingqing Wang, Rong Hu, et al.. (2022). Akkermansia Muciniphila Ameliorates Chronic Kidney Disease Interstitial Fibrosis Via the Gut-Renal Axis. SSRN Electronic Journal. 1 indexed citations

12.

Wang, Fujing, Rong Hu, Jiaxing Zhang, et al.. (2021). High-dose vitamin D3 supplementation ameliorates renal fibrosis by vitamin D receptor activation and inhibiting TGF-β1/Smad3 signaling pathway in 5/6 nephrectomized rats. European Journal of Pharmacology. 907. 174271–174271. 15 indexed citations

13.

Chen, Tong, et al.. (2021). Next frontier in tumor immunotherapy: macrophage-mediated immune evasion. Biomarker Research. 9(1). 72–72. 104 indexed citations

14.

Hu, Rong, Liang Zhao, Tong Chen, et al.. (2020). Metabolic regulation of the bone marrow microenvironment in leukemia. Blood Reviews. 48. 100786–100786. 24 indexed citations

15.

Hu, Rong, Mingqing Wang, Shi-Hao Ni, et al.. (2019). Salidroside ameliorates endothelial inflammation and oxidative stress by regulating the AMPK/NF-κB/NLRP3 signaling pathway in AGEs-induced HUVECs. European Journal of Pharmacology. 867. 172797–172797. 161 indexed citations

16.

Liu, Yang, Lu Lu, Hua Yue, et al.. (2018). Association of expression of ZNF606 gene from monocytes with the risk of coronary artery disease. Clinical Biochemistry. 60. 44–51. 3 indexed citations

17.

Huang, Yanfeng, Wenbo Niu, Rong Hu, et al.. (2018). FIBP knockdown attenuates growth and enhances chemotherapy in colorectal cancer via regulating GSK3β-related pathways. Oncogenesis. 7(9). 77–77. 24 indexed citations

18.

Hu, Rong, Mingqing Wang, Wenbo Niu, et al.. (2018). SKA3 promotes cell proliferation and migration in cervical cancer by activating the PI3K/Akt signaling pathway. Cancer Cell International. 18(1). 183–183. 55 indexed citations

19.

Zhang, Lei, Ying Zhang, Rong Hu, et al.. (2015). Isoflurane Inhibits Embryonic Stem Cell Self-Renewal and Neural Differentiation Through miR-9/E-cadherin Signaling. Stem Cells and Development. 24(16). 1912–1922. 13 indexed citations

20.

Shi, Jiaxin, Jiashu Li, Rong Hu, et al.. (2014). Tristetraprolin is involved in the glucocorticoid-mediated interleukin 8 repression. International Immunopharmacology. 22(2). 480–485. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact